Abstract
To test the hypothesis that the persistent high level of transgene expression of linear DNA eliminating bacterial backbone (LDEBB) results from less cytokine induction in vivo. We systematically investigated the effect of circular DNA (C DNA), linear DNA (L DNA) and LDEBB on gene expression in mice by hydrodynamics-based plasmid administration, and then determined serum cytokine levels in mice by enzyme linked immunosorbent assay (ELISA). The expression of human clotting factor IX (hFIX) gene in mice treated with LDEBB, L DNA or C DNA reached a maximum 1-day after injection (9809, 6447, 2368 ng/mL), respectively. Thirty days after injection, hFIX concentrations dropped to baseline in mice treated with C DNA group, while L DNA group and LDEBB group decreased to 207 and 377 ng/mL, respectively, at the same time-point. Mice receiving LDEBB encoding hFIX expressed approximately 1.5 to 20-fold more serum hFIX than mice injected with L DNA and C DNA for a period of 8 months, respectively. However, mice receiving LDEBB are much less inflammatory than L DNA and C DNA as shown by a 4-fold reduction in serum levels of both TNF-alpha and IL-12. These results demonstrate that LDEBB is not silenced and is capable of expressing persistently ...Continue Reading
References
Sep 1, 1992·Human Molecular Genetics·J A WolffA Jani
Apr 6, 1995·Nature·A M KriegD M Klinman
Jul 1, 1997·European Journal of Immunology·T SparwasserH Wagner
Dec 31, 1997·Human Gene Therapy·L QinJ S Bromberg
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·M A ZantaJ P Behr
Aug 24, 1999·Gene Therapy·F LiuD Liu
Sep 25, 1999·Human Gene Therapy·F Paillard
Sep 25, 1999·Human Gene Therapy·Y TanL Huang
Dec 22, 1999·Gene Therapy·M WhitmoreL Huang
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·Z Y ChenM A Kay
Apr 3, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J YangY Liu
Jun 13, 2001·Gene Therapy·C R HofmanL Huang
Jul 27, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·N S YewS H Cheng
Nov 13, 2001·Gene Therapy·D R GillS C Hyde
Nov 20, 2001·The Journal of Biological Chemistry·Xiaowu LiangPhilip L Felgner
Apr 20, 2002·Science·Zhixiong LiChristopher Baum
Aug 7, 2002·Antisense & Nucleic Acid Drug Development·Weiyin ShenArthur M Krieg
Aug 31, 2002·Cell·Astrid R W SchröderFrederic Bushman
Oct 5, 2002·Gene Therapy·F NicolL C Smith
Oct 24, 2002·Blood·Niels-Bjarne WoodsStefan Karlsson
Jan 17, 2003·The New England Journal of Medicine·Salima Hacein-Bey-AbinaAlain Fischer
Jan 23, 2003·The Journal of Gene Medicine·Michèle LecocqMichel Jadot
May 3, 2003·Nature Reviews. Genetics·Clare E ThomasMark A Kay
Aug 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhi-Ying ChenMark A Kay
Oct 18, 2003·Science·S Hacein-Bey-AbinaM Cavazzana-Calvo
Mar 19, 2004·Gene Therapy·Z Y ChenM A Kay
Feb 11, 2005·Human Gene Therapy·Zhi-Ying ChenMark A Kay
Mar 12, 2005·Nature Reviews. Genetics·Dominic J GloverDavid A Jans
May 27, 2005·Human Gene Therapy·Efren RiuMark A Kay
Jul 19, 2006·FEBS Letters·Huan Zhang ZhuJing Lun Xue
Sep 3, 2008·Science in China. Series C, Life Sciences·H LuJ Xue